Mapping cellular processes that determine delivery of plasmid DNA to the nucleus: application in Chinese hamster ovary and human embryonic kidney cells to enhance protein production.
IF 4.3 3区 工程技术Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
{"title":"Mapping cellular processes that determine delivery of plasmid DNA to the nucleus: application in Chinese hamster ovary and human embryonic kidney cells to enhance protein production.","authors":"James D Budge","doi":"10.3389/fbioe.2025.1466671","DOIUrl":null,"url":null,"abstract":"<p><p>Delivery of DNA into nucleated eukaryotic cells is known as transfection and has been essential in establishing technologies such as recombinant protein production and gene therapy. Considerable research efforts have led to development of a variety of transfection methods for a multitude of applications and cell types. Many methods are efficient in delivering DNA across the plasma membrane but few focus on subsequent delivery into the nucleus, a necessary step in expression of a recombinant transgene, and the cellular processes governing nuclear import of DNA during transfection have proved elusive. Herein, live confocal microscopy was used to track plasmid DNA during transfection of Chinese hamster ovary (CHO) and human embryonic kidney (HEK) cells to map key cellular processes central to nuclear import of DNA showing that there is a strong relationship between events of cell division, promotion of DNA dispersal from endosomes and subsequent nuclear import leading to gene expression. Furthermore, cationic lipid-mediated transfection is more dependent on events of the cell cycle than electroporation to deliver DNA into the nucleus. These findings have informed the design of a method where both CHO and HEK cells are synchronised at G2 phase of the cell cycle followed by timely release enabling cell cycle progression to maximise the frequency of division events immediately after transfection. This led to a 1.2-1.5 fold increase in transfection efficiency for polyethylenimine (PEI) mediated and electroporation transfection respectively. This process enhanced production yields of a monoclonal antibody 4.5 fold in HEK and 18 fold in CHO cells in the first 24 h post transfection. Overall, this study elucidated key cellular processes fundamental to transfection of CHO and HEK cells providing knowledge which can be applied to DNA delivery technologies in a plethora of fields.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1466671"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11969153/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1466671","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Delivery of DNA into nucleated eukaryotic cells is known as transfection and has been essential in establishing technologies such as recombinant protein production and gene therapy. Considerable research efforts have led to development of a variety of transfection methods for a multitude of applications and cell types. Many methods are efficient in delivering DNA across the plasma membrane but few focus on subsequent delivery into the nucleus, a necessary step in expression of a recombinant transgene, and the cellular processes governing nuclear import of DNA during transfection have proved elusive. Herein, live confocal microscopy was used to track plasmid DNA during transfection of Chinese hamster ovary (CHO) and human embryonic kidney (HEK) cells to map key cellular processes central to nuclear import of DNA showing that there is a strong relationship between events of cell division, promotion of DNA dispersal from endosomes and subsequent nuclear import leading to gene expression. Furthermore, cationic lipid-mediated transfection is more dependent on events of the cell cycle than electroporation to deliver DNA into the nucleus. These findings have informed the design of a method where both CHO and HEK cells are synchronised at G2 phase of the cell cycle followed by timely release enabling cell cycle progression to maximise the frequency of division events immediately after transfection. This led to a 1.2-1.5 fold increase in transfection efficiency for polyethylenimine (PEI) mediated and electroporation transfection respectively. This process enhanced production yields of a monoclonal antibody 4.5 fold in HEK and 18 fold in CHO cells in the first 24 h post transfection. Overall, this study elucidated key cellular processes fundamental to transfection of CHO and HEK cells providing knowledge which can be applied to DNA delivery technologies in a plethora of fields.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.